Skip to main content
. 2019 Jul 14;23(9):5907–5919. doi: 10.1111/jcmm.14386

Figure 11.

Figure 11

(A‐C) As evidenced by decrease in tumour volume and weight, suppression of NR2F1‐AS1 could significantly suppress thyroid cancer (TC) tumorigenesis in vivo; (D) The detection of expression levels of NR2F1‐AS1, miR‐338‐3p and cyclin D1 (CCND1) with silence of NR2F1‐AS1; (E) Immunohistochemistry result showed that down‐regulation of NR2F1‐AS1 suppressed TC tumorigenesis in vivo as revealed by change of positive cells, **P < 0.01